by Riley Nolan | Jul 28, 2021 | Featured, Thinking Out Loud -Blog
(Delta) Variants at the Gates Been to the Disco lately? In the Netherlands, dancing is fueling a new wave of COVID infections. You can’t ignore the rise of COVID-19 cases globally after the Delta variant began circulating widely in June. Our hearts go out to...
by Riley Nolan | Jun 28, 2021 | Featured, Thinking Out Loud -Blog
After a year of virtual meetings, EpiVax is thrilled to announce that we will be resuming our much loved Immunogenicity Seminar series in-person, starting Fall 2021! We have an exciting line-up of dates and speakers and we will announce more as they are confirmed....
by Riley Nolan | Jun 10, 2021 | Featured, Thinking Out Loud -Blog
EpiVax has been busy helping our clients, and the research flywheel is spinning faster than ever. We needed more talented folks to pitch in! So far we’ve brought on six wonderful team members in 2021, with more to come soon! Learn more about our new folks below,...
by Annie De Groot | Jun 11, 2020 | Events, Webinars
This webinar has ended, but we invite you to view the recorded recap here. Please join us on July 17, 2020 for our next live webinar, topic TBA! Please extend this invitation to any colleagues or associates you feel would benefit from attending. Participation is...
by Annie De Groot | Feb 26, 2019 | Events
2nd Antigen-Specific Immune Tolerance Drug Development Summit Tuesday, March 26th – Thursday, March 28th, 2019 Wyndham Boston Beacon Hill 5 Blossom Street Boston, Massachusetts 02114 USA Join Dr. Annie De Groot, CEO/CSO EpiVax, at the 2nd Antigen-Specific Immune...